Marios Georgakis: GLP-1 Receptor Agonism as a Promising Approach for cSVD
Marios Georgakis, Research Group Leader and Physician at LMU Munich, Visiting Scientist at Broad Institute of MIT and Harvard University, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”In our new paper, we leverage human genetic data to provide support for GLP-1 receptor agonism as a promising approach for lowering the burden of cerebral small vessel disease (cSVD).
cSVD is a major unmet need in neurology with no available disease-modifying therapies.
It is a devastating and common aging-related pathology that is associated with stroke, dementia, functional decline, and mortality.
Given the strong efficacy of GLP-1 receptor agonists in reducing atherosclerotic cardiovascular disease, and the known impact of diabetes and obesity on the microvasculature, we explored if human genetic data support for their repurposing for cSVD.
Using genetic variants in the GLP1R locus that mimicked the HbA1c- or BMI-lowering effects of GLP-1 receptor agonists, we ran drug target Mendelian randomization and found associations with
- Lower risk of lacunar (or small vessel) stroke, a clinical cSVD manifestation
- Lower volume of white matter hyperintensities, the most widely used imaging biomarker of cSVD.
These findings provide human genetic support for evaluating GLP-1 receptor agonists in clinical trials targeting cSVD.”
Title: Genetically Simulated GLP-1 Receptor Agonism and Cerebral Small Vessel Disease
Authors: Panagiotis Zangas, Murad Omarov, Marios K. Georgakis
Read the Full Article on Neurology Genetics

Stay updated on all scientific advances with Hemostasis Today.
-
Apr 26, 2026, 10:44Regan Bucciol: Unforgettable Science and Mentorship Moments at ISLH 2026
-
Apr 26, 2026, 10:21Aynetu Girma Moges: Major Cardiovascular Changes in Pregnancy
-
Apr 26, 2026, 07:10Mouna Sassi: Viscoelastic Evidence of Altered Clot Stability in Pediatric Edoxaban Overdose
-
Apr 26, 2026, 07:02Matías J. Alet: Reflections on Stroke Care and Brain-Heart Interaction at Stroke Congress 2026
-
Apr 26, 2026, 06:53Azizah Zakaria: Stroke Guard’s Journey – From Student Innovation to Award-Winning Impact
-
Apr 26, 2026, 06:45Ifeanyichukwu Ifechidere: Developing Diagnostic Reasoning in Coagulation Testing
-
Apr 26, 2026, 06:33Ellen Norris: 2025 Premier Award Honors Contributions to the Hemophilia Community
-
Apr 26, 2026, 06:32Flavia Evangeline: Acute Heat Stroke Care – Nursing Role in Prevention of Organ Failure and Death
-
Apr 26, 2026, 06:28Brian Mahony: Real-World Positioning of Rebalancing Agents